← Back to Search

Modified Time-restricted Feeding for Non-alcoholic Fatty Liver Disease

N/A
Waitlist Available
Led By Essam M Imseis, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Motivated obese fatty liver patients aged 8 -18yrs with ALT >80
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline; 3 months
Awards & highlights

Study Summary

The purpose of the study is to examine the effects of modified time-restricted feeding and conventional dietary approaches in motivated obese fatty liver patients on biochemical markers, imaging studies, and anthropometric measurements.

Eligible Conditions
  • Non-alcoholic Fatty Liver Disease

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline; 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline; 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Alanine Amino Transferase (ALT) levels
Secondary outcome measures
Change in Body Mass Index (BMI) Z-score
Change in HDL
Change in LDL
+9 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Modified Time-restricted FeedingExperimental Treatment3 Interventions
Group II: Conventional dietActive Control3 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Physical activity
2011
Completed Phase 2
~4740

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
909 Previous Clinical Trials
323,701 Total Patients Enrolled
3 Trials studying Non-alcoholic Fatty Liver Disease
78 Patients Enrolled for Non-alcoholic Fatty Liver Disease
Essam M Imseis, MDPrincipal InvestigatorThe University of Texas Health Sciences Center in Houston

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Effect of Modified Time-restricted Feeding in Preventing Progression of Non-Alcoholic Fatty Liver Disease (NAFLD).
Essam M. Imseis 2019. "Effect of Modified Time-restricted Feeding in Preventing Progression of Non-Alcoholic Fatty Liver Disease (NAFLD).". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03848390.
All > Nafld
~7 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top